[The combined treatment of bronchial carcinoma (author's transl)].
A preliminary assessment of a chemotherapeutic study is presented. The polychemotherapy was given as a high dosage intermittent stosstherapy with 3 infusions at intervals of a week for 3 years. The group of randomized controls included 126 patients who were classified according to the stage classification of the TNM system and Feinstein's system, which takes into account the clinical symptoms. Comparison of the death rates with the controls shows a distinct advantage in favor of the patients treated chemotherapeutically in all TNM classes.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D014747:Vinblastine / Q000627:therapeutic use*
D014747:Vinblastine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Zur kombinierten Behandlung des Bronchuskarzinoms